• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Genes Dis. The clinical and immunological features of pediatric COVID-19 patients in China

tetano

Editor, Senior Moderator
Genes Dis. 2020 Apr 14. doi: 10.1016/j.gendis.2020.03.008. [Epub ahead of print]
The clinical and immunological features of pediatric COVID-19 patients in China.


Chen J[SUP]1[/SUP], Zhang ZZ[SUP]2[/SUP], Chen YK[SUP]3[/SUP], Long QX[SUP]1[/SUP], Tian WG[SUP]4[/SUP], Deng HJ[SUP]1[/SUP], Hu JL[SUP]1[/SUP], Zhang XX[SUP]5[/SUP], Pu-Liao[SUP]6[/SUP], Xiang JL[SUP]7[/SUP], Wang DX[SUP]8[/SUP], Hu P[SUP]1[/SUP], Zhou FC[SUP]9[/SUP], Li ZJ[SUP]5[/SUP], Xu HM[SUP]2[/SUP], Cai XF[SUP]1[/SUP], Wang DQ[SUP]1[/SUP], Hu Y[SUP]1[/SUP], Tang N[SUP]1[/SUP], Liu BZ[SUP]10[/SUP], Wu GC[SUP]11[/SUP], Huang AL[SUP]1[/SUP].

Author information




Abstract

In December 2019, the corona virus disease 2019 (COVID-19) caused by novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information on clinical features and immunological profile of COVID-19 in paediatrics. The clinical features and treatment outcomes of twelve paediatric patients confirmed as COVID-19 were analyzed. The immunological features of children patients was investigated and compared with twenty adult patients. The median age was 14.5-years (range from 0.64 to 17), and six of the patients were male. The average incubation period was 8 days. Clinically, cough (9/12, 75%) and fever (7/12, 58.3%) were the most common symptoms. Four patients (33.3%) had diarrhea during the disease. As to the immune profile, children had higher amount of total T cell, CD8+ T cell and B cell but lower CRP levels than adults (P < 0.05). Ground-glass opacity (GGO) and local patchy shadowing were the typical radiological findings on chest CT scan. All patients received antiviral and symptomatic treatment and the symptom relieved in 3-4 days after admitted to hospital. The paediatric patients showed mild symptom but with longer incubation period. Children infected with SARS-CoV-2 had different immune profile with higher T cell amount and low inflammatory factors level, which might ascribed to the mild clinical symptom. We advise that nucleic acid test or examination of serum IgM/IgG antibodies against SARS-CoV-2 should be taken for children with exposure history regardless of clinical symptom.
? 2020 Chongqing Medical University. Production and hosting by Elsevier B.V.



KEYWORDS:

COVID-19; Clinical features; Immune; Paediatrics; SARS-CoV-2


PMID:32363222PMCID:PMC7194810DOI:10.1016/j.gendis.2020.03.008
Free full text
 
Back
Top Bottom